MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10549-021-06428-9

Медицинская библиотека · Breast cancer research and treatment · 2021

Oncologic outcomes of immediate breast reconstruction in young women with breast cancer receiving neoadjuvant chemotherapy.

Wu Zhen-Yu, Kim Hee Jeong, Lee Jongwon, Chung Il Yong, Kim Jisun, Lee Sae Byul, Son Byung-Ho, Kim Eun Key, Jeong Jae Ho, Lee Hee Jin, Chae Eun Young, Jung Jinhong, Ahn Sei-Hyun, Ko BeomSeok

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Oncologic safety of postmastectomy breast reconstruction in young women with breast cancer is not well-defined, especially in the setting of neoadjuvant chemotherapy (NACT). We retrospectively compared the oncologic outcomes following nipple-sparing (NSM)/skin-sparing mastectomy (SSM) with immediate breast reconstruction (IBR) and conventional mastectomy (CM) alone in young breast cancer patients after NACT.

METHODS

A total of 1266 women with primary breast cancer who underwent NACT followed by total mastectomy with or without IBR were reviewed. Of these, only young patients (age ≤ 40 years at diagnosis) were included in the outcome analysis (n = 375). After propensity score-matching by clinical T and N stage, molecular subtype, response to NACT, and adjuvant radiotherapy status, 228 patients were 1:1 matched, comprising balanced IBR group (with NSM/SSM) and CM-alone group.

RESULTS

The 5-year locoregional recurrence-free, disease-free, distant metastasis (DM)-free, and breast cancer-specific survival (BCSS) rates for the entire cohort of young patients were 83.4%, 65.3%, 71.7%, and 85.4%, respectively. Locoregional recurrence rates between the matched groups were similar (14% vs. 15.8%; p = 0.710); however, IBR group had significantly lower DM rate (27.2% vs. 40.4%; p = 0.036) and breast cancer mortality (14.9% vs. 27.2%; p = 0.023) than CM-alone group. IBR group showed significantly improved 5-year DM-free survival (74.1% vs. 62.6%; p = 0.043) and BCSS (89.1% vs. 77.6%; p = 0.048) rates than CM-alone group.

CONCLUSIONS

Our results indicated that IBR with NSM/SSM does not negatively affect long-term oncologic outcomes compared to CM alone in young women with breast cancer receiving NACT.

Для цитирования: Wu Zhen-Yu, Kim Hee Jeong, Lee Jongwon, Chung Il Yong, Kim Jisun, Lee Sae Byul, Son Byung-Ho, Kim Eun Key, Jeong Jae Ho, Lee Hee Jin, Chae Eun Young, Jung Jinhong, Ahn Sei-Hyun, Ko BeomSeok. Oncologic outcomes of immediate breast reconstruction in young women with breast cancer receiving neoadjuvant chemotherapy.. Breast cancer research and treatment. 2021. DOI: 10.1007/s10549-021-06428-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.